Related Experiment Videos
[Changes in blood coagulation in HIV infection]
1Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA 19140, USA.
Summary
HIV infection often causes complex hemostatic abnormalities, most commonly HIV-related thrombocytopenia (Tr-HIV). Understanding these bleeding and clotting issues is key for better patient care.
Area of Science:
- Hematology
- Infectious Diseases
- Immunology
Context:
- Human immunodeficiency virus (HIV) infection presents complex clinical challenges.
- Hemostatic abnormalities are frequent complications in HIV-positive patients.
- HIV-related thrombocytopenia (Tr-HIV) is a prevalent disorder impacting diverse patient groups.
Purpose:
- To elucidate the mechanisms and clinical significance of hemostatic abnormalities in HIV infection.
- To review the pathogenesis of HIV-related thrombocytopenia, including bone marrow failure and immunological factors.
- To discuss coagulation cascade dysfunctions and thrombotic complications associated with HIV.
Summary:
- HIV-related thrombocytopenia (Tr-HIV) arises from bone marrow failure or immune-mediated platelet destruction.
- Zidovudine is the primary treatment for Tr-HIV, with other options showing less efficacy.
- Coagulation abnormalities, lupus anticoagulants, anticardiolipin antibodies, and altered natural anticoagulants contribute to bleeding or thrombosis risk.
- HIV-associated thrombotic thrombocytopenic purpura shares clinical features and treatment strategies with the classical form.
Impact:
- Enhanced understanding of hemostatic disorders in HIV facilitates more rational and effective patient management.
- Knowledge of these abnormalities aids in predicting and mitigating bleeding or thrombotic events.
- This information supports improved clinical decision-making for HIV-infected individuals with hematological complications.